AbbVie and Eisai Announce the Launch of HUMIRA Pen an AutoInjector Formulation for Fully Human AntiTNFalpha Monoclonal Antibody HUMIRA

TOKYO Jun 11 2018 JCN Newswire AbbVie GK Eisai Co. Ltd. and Eisai's subsidiary for gastrointestinal diseases EA Pharma Co. Ltd.announced that the autoinjection delivery system for HUMIRA generic name adalimumab recombinant "HUMIRA&amp...